Phreesia Set to Report Q1 2023 Earnings: A Deep Dive into the Data

🌥️It’s that time again when investors and financial analysts eagerly anticipate the earnings report of Phreesia (PHR), the healthcare software-as-a-service (SaaS) company that helps medical practices automate patient intake and registration. The company is scheduled to release its first-quarter results on May 31, 2023, at 5:00 PM Eastern Standard Time. With a year-to-date stock price decline of around 3%, many investors are hoping for positive news from the upcoming earnings call. Let’s take a closer look at some key data points surrounding Phreesia’s upcoming earnings report.

Fundamental Analysis

On the fundamental front, Phreesia has been showing steady revenue growth over the past year. For the last quarter reported, Q4 2022, the company’s total revenue stood at $76.6 million, an increase of 5.3% from the previous quarter. Despite the revenue growth, Phreesia posted a negative net income of $38 million in Q4, but this was still an improvement from Q3’s net income of $40.2 million. The company has reported negative net income for the past five quarters; however, if the trend seen between Q3 and Q4 continues in Q1, Phreesia could trend towards profitability. It is important to note that the EPS consensus estimates for Q1 from MorningStar have remained steady at $0.99 for the past 30 and 90 days.

Technical Analysis

To gain a better understanding of what has been happening with Phreesia‘s stock price performance in recent months, let’s look at some technical analysis data. The first point to note is that Phreesia‘s stock price has declined by 3% over the past month and 14.8% over the last quarter. However, there have been some positive signals from the stock’s price trend. The stock’s low point over the past three months was $27.7 on February 22, 2023, and it has since recovered to hover around $30.3. A technical analyst might view this as a potential uptrend reversal, and if the price continues to trend up, the stock price could see strong gains.

Historical Guidance

Looking back on Phreesia‘s previous earning calls, the company has a mixed track record of exceeding or missing EPS estimates. In Q4 2022, Phreesia missed MorningStar’s EPS estimate by $0.18, posting an adjusted EPS of -$0.72 compared to the estimated -$0.54. However, in Q3 2022, Phreesia exceeded the EPS estimate by $0.01, reporting -$0.76 compared to the estimated -$0.77. In Q2 2022, they missed the EPS estimate by $0.06, recording -$0.89 compared to the estimated -$0.83. In Q1 2022, Phreesia reported an adjusted EPS of -$0.99, which was in line with MorningStar’s estimate for the quarter.

Analysts’ Estimates

It’s always important to consider analysts’ estimates when assessing a company’s expected earnings performance. According to the latest data from MorningStar, discussed earlier, Phreesia is expected to record an adjusted EPS of -$0.99 for Q1 2023. The consensus among six analysts covering Phreesia is that the company will post an earnings per share loss of $1.00 for the quarter ending April 30th, 2023. These estimates have not changed over the past month.

Conclusion

In conclusion, while Phreesia‘s historical earning track record has been mixed, there are some positive trends to be optimistic about ahead of the upcoming earnings call. The company has recorded steady revenue growth over the past year, and if the trend between Q3 and Q4 continues, Phreesia may trend towards profitability. The technical analysis suggests that the stock price could see potential gains if it continues to trend up, despite recent declines. Finally, analysts’ estimates expect Phreesia to report an adjusted EPS of -$0.99 for Q1 2023, with a consensus estimate of -$1.00. This earnings report will be instrumental as investors and financial analysts evaluate Phreesia‘s financial performance and determine whether or not to invest in the company.

If you are interested in learning more about Phreesia‘s Q1 2023 earnings, be sure to tune in to the earnings call on May 31, 2023, at 5:00 PM EST.